1. Home
  2. JG vs CING Comparison

JG vs CING Comparison

Compare JG & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Mobile Limited

JG

Aurora Mobile Limited

HOLD

Current Price

$7.66

Market Cap

40.6M

Sector

Technology

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.89

Market Cap

40.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JG
CING
Founded
2012
2012
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.6M
40.5M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
JG
CING
Price
$7.66
$5.89
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
7.6K
285.0K
Earning Date
03-12-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,967,244.00
N/A
Revenue This Year
$10.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
20.78
N/A
52 Week Low
$5.85
$3.20
52 Week High
$20.94
$6.74

Technical Indicators

Market Signals
Indicator
JG
CING
Relative Strength Index (RSI) 56.74 65.10
Support Level $6.71 $4.80
Resistance Level $8.10 $6.74
Average True Range (ATR) 0.56 0.61
MACD 0.06 0.01
Stochastic Oscillator 58.89 61.38

Price Performance

Historical Comparison
JG
CING

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: